-
1
-
-
0242515765
-
Analysis of the active components of silymarin
-
Kvasnicka F., Biba B., Sevcik R., Voldrich M., Kratka J. Analysis of the active components of silymarin. J. Chromatogr. A 2003, 990:239-245.
-
(2003)
J. Chromatogr. A
, vol.990
, pp. 239-245
-
-
Kvasnicka, F.1
Biba, B.2
Sevcik, R.3
Voldrich, M.4
Kratka, J.5
-
2
-
-
77955057266
-
Advances in the pharmaceutical research on the silymarin
-
Yang J., Liu Y.M., Liu Y.Z. Advances in the pharmaceutical research on the silymarin. Nat. Prod. Res. Dev. 2004, 16:185-187.
-
(2004)
Nat. Prod. Res. Dev.
, vol.16
, pp. 185-187
-
-
Yang, J.1
Liu, Y.M.2
Liu, Y.Z.3
-
3
-
-
0031044521
-
Free radical scavenging and antioxidative properties of 'silibin' complexes on microsomal lipid peroxidation
-
Basaga H., Poli G., Tekkaya C., Aras I. Free radical scavenging and antioxidative properties of 'silibin' complexes on microsomal lipid peroxidation. Cell Biochem. Funct. 1997, 15:27-33.
-
(1997)
Cell Biochem. Funct.
, vol.15
, pp. 27-33
-
-
Basaga, H.1
Poli, G.2
Tekkaya, C.3
Aras, I.4
-
4
-
-
0030796417
-
Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats
-
Boigk G., Stroedter L., Herbst H. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997, 26:643-649.
-
(1997)
Hepatology
, vol.26
, pp. 643-649
-
-
Boigk, G.1
Stroedter, L.2
Herbst, H.3
-
5
-
-
0032239998
-
A review of plants used in the treatment of liver disease, Part 1
-
Luper S. A review of plants used in the treatment of liver disease, Part 1. Altern. Med. Rev. 1998, 3:410-421.
-
(1998)
Altern. Med. Rev.
, vol.3
, pp. 410-421
-
-
Luper, S.1
-
6
-
-
33750263327
-
Milk thistle: silybum marianum
-
Pepping J. Milk thistle: silybum marianum. Am. J. Health Syst. Pharm. 1999, 56:1195-1197.
-
(1999)
Am. J. Health Syst. Pharm.
, vol.56
, pp. 1195-1197
-
-
Pepping, J.1
-
7
-
-
0032008339
-
Milk thistle (silybum marianum) for the therapy of liver disease
-
Flora K., Hahn M., Rosen H., Benner K. Milk thistle (silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 1998, 93:139-143.
-
(1998)
Am. J. Gastroenterol.
, vol.93
, pp. 139-143
-
-
Flora, K.1
Hahn, M.2
Rosen, H.3
Benner, K.4
-
8
-
-
0037109597
-
Milk thistle for the treatment of liver disease: a systematic review and meta-analysis
-
Jacobs B.P., Dennehy C., Ramirez G., Sapp J., Lawrence V.A. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. Am. J. Med. 2002, 113:506-515.
-
(2002)
Am. J. Med.
, vol.113
, pp. 506-515
-
-
Jacobs, B.P.1
Dennehy, C.2
Ramirez, G.3
Sapp, J.4
Lawrence, V.A.5
-
9
-
-
30744437915
-
Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation
-
El-Samaligy M.S., Afifi N.N., Mahmoud E.A. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. IpHarm 2006, 308:140-148.
-
(2006)
IpHarm
, vol.308
, pp. 140-148
-
-
El-Samaligy, M.S.1
Afifi, N.N.2
Mahmoud, E.A.3
-
10
-
-
33845256894
-
Determination of equilibrium solubility of silybinin in various medium and its apparent oil/water partition coefficient
-
Zhang T.T., Xu W., Hu S.L., He Z.G. Determination of equilibrium solubility of silybinin in various medium and its apparent oil/water partition coefficient. Chin. Pharm. J. 2006, 41:1569-1571.
-
(2006)
Chin. Pharm. J.
, vol.41
, pp. 1569-1571
-
-
Zhang, T.T.1
Xu, W.2
Hu, S.L.3
He, Z.G.4
-
11
-
-
38649102798
-
Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique
-
Sun N.Y., Wei X.L., Wu B.J., Chen J., Lu Y., Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powder Technol. 2008, 182:72-80.
-
(2008)
Powder Technol.
, vol.182
, pp. 72-80
-
-
Sun, N.Y.1
Wei, X.L.2
Wu, B.J.3
Chen, J.4
Lu, Y.5
Wu, W.6
-
12
-
-
33846839082
-
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS
-
Woo J.S., Kim T.S., Park J.H., Chi S.C. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch. Pharm. Res. 2007, 30:82-89.
-
(2007)
Arch. Pharm. Res.
, vol.30
, pp. 82-89
-
-
Woo, J.S.1
Kim, T.S.2
Park, J.H.3
Chi, S.C.4
-
13
-
-
35548931533
-
Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application
-
Wu J.W., Lin L.C., Hung S.C., Chi C.W., Tsai T.H. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. Pharm. Biomed. Anal. 2007, 45:635-641.
-
(2007)
Pharm. Biomed. Anal.
, vol.45
, pp. 635-641
-
-
Wu, J.W.1
Lin, L.C.2
Hung, S.C.3
Chi, C.W.4
Tsai, T.H.5
-
14
-
-
0026698773
-
A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations
-
Arcari M., Brambilla A., Brandt A., Caponi R., Corsi G., Di Rella M., Solinas F., Wachter W.P. A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations. Boll. Chim. Farm. 1992, 131:205-209.
-
(1992)
Boll. Chim. Farm.
, vol.131
, pp. 205-209
-
-
Arcari, M.1
Brambilla, A.2
Brandt, A.3
Caponi, R.4
Corsi, G.5
Di Rella, M.6
Solinas, F.7
Wachter, W.P.8
-
15
-
-
33745891184
-
Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs
-
Xiao Y.Y., Song Y.M., Chen Z.P., Ping Q.N. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs. Int. J. Pharm. 2006, 319:162-168.
-
(2006)
Int. J. Pharm.
, vol.319
, pp. 162-168
-
-
Xiao, Y.Y.1
Song, Y.M.2
Chen, Z.P.3
Ping, Q.N.4
-
16
-
-
33646854907
-
Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system
-
Wu W., Wang Y., Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 2006, 63:288-294.
-
(2006)
Eur. J. Pharm. Biopharm.
, vol.63
, pp. 288-294
-
-
Wu, W.1
Wang, Y.2
Que, L.3
-
17
-
-
24344509856
-
Preparation of silybin-phospholipid complex and its bioavailability in rats
-
Xiao Y.Y., Song Y.M., Chen Z.P., Ping Q.N. Preparation of silybin-phospholipid complex and its bioavailability in rats. Acta Pharmacol. Sin. 2005, 40:611-617.
-
(2005)
Acta Pharmacol. Sin.
, vol.40
, pp. 611-617
-
-
Xiao, Y.Y.1
Song, Y.M.2
Chen, Z.P.3
Ping, Q.N.4
-
18
-
-
59649097447
-
Lipid nanoparticles for parenteral delivery of actives
-
Joshi M.D., Müller R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 2009, 71:161-172.
-
(2009)
Eur. J. Pharm. Biopharm.
, vol.71
, pp. 161-172
-
-
Joshi, M.D.1
Müller, R.H.2
-
19
-
-
4544275025
-
Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles
-
Müller R.H., Keck C.M. Challenges and solutions for the delivery of biotech drugs-a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 2004, 113:151-170.
-
(2004)
J. Biotechnol.
, vol.113
, pp. 151-170
-
-
Müller, R.H.1
Keck, C.M.2
-
20
-
-
61349119286
-
Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers
-
Yang X.G., Li L.B., Wang Y.X., Tan Y.B. Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers. Int. J. Pharm. 2009, 370:210-215.
-
(2009)
Int. J. Pharm.
, vol.370
, pp. 210-215
-
-
Yang, X.G.1
Li, L.B.2
Wang, Y.X.3
Tan, Y.B.4
-
21
-
-
33845895263
-
Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo
-
Xing J., Zhang D.R., Tan T.W. Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo. Int. J. Biol. Macromol. 2007, 40:153-158.
-
(2007)
Int. J. Biol. Macromol.
, vol.40
, pp. 153-158
-
-
Xing, J.1
Zhang, D.R.2
Tan, T.W.3
-
22
-
-
0343618485
-
Characterisation of a novel solid-lipid nanoparticles carrier system based on binary mixtures of liquid and solid-lipids
-
Jenning V., Thünemann A.F., Gohla S.H. Characterisation of a novel solid-lipid nanoparticles carrier system based on binary mixtures of liquid and solid-lipids. Int. J. Pharm. 2000, 199:167-177.
-
(2000)
Int. J. Pharm.
, vol.199
, pp. 167-177
-
-
Jenning, V.1
Thünemann, A.F.2
Gohla, S.H.3
-
23
-
-
2242472082
-
Solid-lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
-
Müller R.H., Radtke M., Wissing S.A. Solid-lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 2002, 54:S131-S155.
-
(2002)
Adv. Drug Deliv. Rev.
, vol.54
-
-
Müller, R.H.1
Radtke, M.2
Wissing, S.A.3
-
24
-
-
0037151496
-
Nanostructured lipid matrices for improved microencapsulation of drugs
-
Müller R.H., Radtke M., Wissing S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm. 2002, 242:121-128.
-
(2002)
Int. J. Pharm.
, vol.242
, pp. 121-128
-
-
Müller, R.H.1
Radtke, M.2
Wissing, S.A.3
-
25
-
-
73349104688
-
HPLC determination of entrapment efficiency of matrine-loaded albumin nanoparticles
-
Zou D.N., Zhang D.R., Zhou X.H. HPLC determination of entrapment efficiency of matrine-loaded albumin nanoparticles. Chin. J. Pharm. Anal. 2008, 28:93-96.
-
(2008)
Chin. J. Pharm. Anal.
, vol.28
, pp. 93-96
-
-
Zou, D.N.1
Zhang, D.R.2
Zhou, X.H.3
-
26
-
-
0037177516
-
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability
-
Müller R.H., Jacobs C. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int. J. Pharm. 2002, 237:151-161.
-
(2002)
Int. J. Pharm.
, vol.237
, pp. 151-161
-
-
Müller, R.H.1
Jacobs, C.2
-
27
-
-
0035937599
-
Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future
-
Müller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47:3-19.
-
(2001)
Adv. Drug Deliv. Rev.
, vol.47
, pp. 3-19
-
-
Müller, R.H.1
Jacobs, C.2
Kayser, O.3
-
28
-
-
17444418329
-
Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures
-
Marcos G.F., Maria J.A., Dolores T. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. J. Colloid Interface Sci. 2005, 285:590-598.
-
(2005)
J. Colloid Interface Sci.
, vol.285
, pp. 590-598
-
-
Marcos, G.F.1
Maria, J.A.2
Dolores, T.3
-
29
-
-
33646081517
-
Preparation and characteristics of monostearin nanostructured lipid carriers
-
Hu F.Q., Jiang S.P., Du Y.Zh., Yuan H., Ye Y.Q., Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 2006, 314:83-89.
-
(2006)
Int. J. Pharm.
, vol.314
, pp. 83-89
-
-
Hu, F.Q.1
Jiang, S.P.2
Du, Y.3
Yuan, H.4
Ye, Y.Q.5
Zeng, S.6
-
31
-
-
0028548631
-
Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles
-
Siekmann B., Westesen K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Colloids Surf. B: Biointerfaces 1994, 3:159-175.
-
(1994)
Colloids Surf. B: Biointerfaces
, vol.3
, pp. 159-175
-
-
Siekmann, B.1
Westesen, K.2
-
32
-
-
0037404980
-
The production and characteristics of solid-lipid nanoparticles (SLNs)
-
Hou D.Z., Xie C.S., Huang K.J., Zhu C.H. The production and characteristics of solid-lipid nanoparticles (SLNs). Biomaterials 2003, 24:1781-1785.
-
(2003)
Biomaterials
, vol.24
, pp. 1781-1785
-
-
Hou, D.Z.1
Xie, C.S.2
Huang, K.J.3
Zhu, C.H.4
-
33
-
-
26244444984
-
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system
-
Hu F.Q., Jiang S.P., Du Y.Z., Yuan H., Ye Y.Q., Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B 2005, 45:167-173.
-
(2005)
Colloids Surf. B
, vol.45
, pp. 167-173
-
-
Hu, F.Q.1
Jiang, S.P.2
Du, Y.Z.3
Yuan, H.4
Ye, Y.Q.5
Zeng, S.6
-
34
-
-
0029857983
-
Atomic force microscopy studies of solid-lipid nanoparticles
-
Mühlen A.Z., Mühlen E.Z., Niehus H., Mehnert W. Atomic force microscopy studies of solid-lipid nanoparticles. Pharm. Res. 1996, 13:1411-1416.
-
(1996)
Pharm. Res.
, vol.13
, pp. 1411-1416
-
-
Mühlen, A.Z.1
Mühlen, E.Z.2
Niehus, H.3
Mehnert, W.4
-
35
-
-
0029946237
-
Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications
-
Siauve N., Clément O., Cuénod C.A., Benderbous S., Frija G. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications. Magn. Reson. Imaging 1996, 14:381-390.
-
(1996)
Magn. Reson. Imaging
, vol.14
, pp. 381-390
-
-
Siauve, N.1
Clément, O.2
Cuénod, C.A.3
Benderbous, S.4
Frija, G.5
-
36
-
-
0032950389
-
Body distribution in mice of intravenously injected camptothecin solid-lipid nanoparticles and targeting effect on brain
-
Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang Z.Y. Body distribution in mice of intravenously injected camptothecin solid-lipid nanoparticles and targeting effect on brain. J. Control Release 1999, 59:299-307.
-
(1999)
J. Control Release
, vol.59
, pp. 299-307
-
-
Yang, S.C.1
Lu, L.F.2
Cai, Y.3
Zhu, J.B.4
Liang, B.W.5
Yang, Z.Y.6
-
37
-
-
0032472296
-
Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats
-
Löbenberg R., Araujo L., von Briesen H., Rodgers E., Kreuter J. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. J. Control Release 1998, 50:21-30.
-
(1998)
J. Control Release
, vol.50
, pp. 21-30
-
-
Löbenberg, R.1
Araujo, L.2
von Briesen, H.3
Rodgers, E.4
Kreuter, J.5
-
38
-
-
0029379738
-
Delivery of antimicrobials to infected tissue macrophages
-
Bakker-Woudenberg I.A.J.M. Delivery of antimicrobials to infected tissue macrophages. Adv. Drug Deliv. Rev. 1995, 17:5-20.
-
(1995)
Adv. Drug Deliv. Rev.
, vol.17
, pp. 5-20
-
-
Bakker-Woudenberg, I.A.J.M.1
|